Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: An Age-Old Tale with a New Twist

Sex Differences in Outcomes After LVAD Implant

Lipids 2024 Update

Realities of Living with High Lipoprotein(a)

Атеросклероз: невидимый процесс, который начинается в молодости

Top 10 Advances in Lipid Management - Seth Martin, MD

Advances in Lipoprotein (a) | Cardiology Grand Rounds

2020 FH Global Summit Session 4: Lp(a) and Drivers of Inherited Risk

Анализ вашей панели холестерина и анализов на метаболическое здоровье — полное руководство | Докт...

Увлекательный мир липопротеина(а)

“Current Guidelines for the Management of Stable Ischemic Heart Disease”, with Dr. George Vetrovec

Lp(a) Explained: Genetics, Risk, and What You Can Actually Do

Emory Cardiology Friday Fellows Conference 09-11-2020

Biophysics of Heart Disease & Why Atherosclerosis is NOT a Cholesterol Problem | Dr Stephen Hussey

Lp(a) - My Viewpoint

Lipoprotein(a): An ASCVD Risk Factor That Can No Longer Be Ignored

Lipoprotein(a) in Coronary Disease: An Emerging Novel Target (Steven E Nissen, MD) February 14, 2019

The Role of Non-Statin Therapies in Optimal Cholesterol Management

What is Lp(a) and what is its relationship with cardiovascular disease risk? | Benoît Arsenault

Part 1 | CCS ESC guideline 2024 | Dr. Sedqi Alkubati

Cholesterol: The Good, The Bad, and Lipoprotein (a)